¼­»ó¿ø ¸íÀÇ

Ä¡¸ÅÄ¡·áÀÇ ÆÐ·¯´ÙÀÓÀ» ¼±µµÇÏ´Â Ä¡¸Å ±ÇÀ§ÀÚ

¼­»ó¿ø ¸íÀÇ

  • ¼Ò ¼Ó
    »ï¼º¼­¿ïº´¿ø
  • Áø·á°ú
    ½Å°æ°ú
  • Àü¹®ºÐ¾ß
    °æµµÀÎÁöÀå¾Ö, ¾ËÂêÇÏÀ̸Ӻ´(Alzheimerº´), ÁÖ°üÀû±â¾ïÀå¾Ö, Ç÷°ü¼ºÄ¡¸Å, ±â¾ïÀå¾Ö, °Ç¸ÁÁõ, ³ëÈ­

¼­»ó¿ø ±³¼ö´Â Ä¡¸Å Ä¡·áÀÇ ÆÐ·¯´ÙÀÓÀ» ¹Ù²Ù¾î °¡´Â Àι°·Î À¯¸íÇÏ´Ù. 2025³â ¹Ì±¹ ¾ËÃ÷ÇÏÀ̸ÓÇÐȸ¿¡¼­ ¹ßÇàÇÏ´Â Ä¡¸Å ºÐ¾ß Àú¸í ±¹Á¦ ÇмúÁöÀÎ ¿¡ ¾ËÃ÷ÇÏÀ̸Ӻ´ÀÇ ´Ü°èº° Áø´Ü °úÁ¤¿¡¼­ ´Ù¾çÇÑ Ç÷¾× ±â¹Ý ¹ÙÀÌ¿À¸¶Ä¿ÀÇ Â÷º°ÀûÀÎ ¿ªÇÒÀ» ¹àÇô³½ ¿¬±¸¸¦ ¹ßÇ¥Çß´Ù. ÀÌ ¿¬±¸´Â Ä¡¸Å Áø´Ü°ú Ä¡·á Àü·«À» ¼¼¿ì´Â µ¥ »õ·Î¿î ¹æÇâÀ» Á¦½ÃÇÑ´Ù. ¶ÇÇÑ, ÇöÀç °­³²±¸Ä¡¸Å¾È½É¼¾ÅÍÀåÀ» ¸Ã°í ÀÖÀ¸¸ç, 2021³â¿¡´Â Ä¡¸Å±Øº¹ÀÇ ³¯À» ±â³äÇØ ´ëÅë·É ǥâÀ» ¼ö»óÇÏ´Â µî Ä¡¸Å °ü·Ã ¿¬±¸»Ó¸¸ ¾Æ´Ï¶ó »çȸÀûÀÎ ÀÎ½Ä °³¼±°ú ȯÀÚ Áö¿ø¿¡µµ Àû±ØÀûÀ¸·Î ±â¿©Çϰí ÀÖ´Ù. ±¹³» Ä¡¸Å ºÐ¾ßÀÇ ±ÇÀ§Àڷμ­, Á¶±â Áø´Ü ¹× ¸ÂÃã Ä¡·á¸¦ ¼±µµÇÏ´Â ÇÙ½ÉÀûÀÎ ¿ªÇÒÀ» ¼öÇàÇϰí ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • ¿¬¼¼´ë ÀÇ´ë Çлç
  • ¿¬¼¼´ë ÀÇ´ë ¼®»ç
  • ¿¬¼¼´ë ÀÇ´ë ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience

ÇÐȸȰµ¿

Academic activities
  • 2023 ~ ÇöÀç´ëÇѳú±â´É¸ÅÇÎÇÐȸ À繫ÀÌ»ç
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 0°Ç
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Temporal Dynamics and Biological Variability of Alzheimer Biomarkers
¹ßÇ¥³âµµ 2025 ¹ßÇ¥Áö JAMA Neurology
Á¦ ¸ñ Cross-ancestry genome-wide association study identifies implications of SORL1 in cerebral beta-amyloid deposition
¹ßÇ¥³âµµ 2025 ¹ßÇ¥Áö Nature Communications
Á¦ ¸ñ Whole-genome sequencing analyses suggest novel genetic factors associated with Alzheimer's disease and a cumulative effects model for risk liability
¹ßÇ¥³âµµ 2025 ¹ßÇ¥Áö Nature Communications
Á¦ ¸ñ Plasma Alzheimer's disease biomarker variability: Amyloid-independent and amyloid-dependent factors
¹ßÇ¥³âµµ 2025 ¹ßÇ¥Áö Alzheimer¡¯s & Dementia
Á¦ ¸ñ Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnostics
¹ßÇ¥³âµµ 2025 ¹ßÇ¥Áö Alzheimer¡¯s & Dementia
Á¦ ¸ñ Integrating visual assessments and quantification methods for tau PET staging
¹ßÇ¥³âµµ 2025 ¹ßÇ¥Áö Alzheimer¡¯s & Dementia
Á¦ ¸ñ Age-related amyloid beta dynamics modeled with the generalized additive model for location, scale, and shape (GAMLSS) across diverse populations: Cross-sectional trajectories and longitudinal validation
¹ßÇ¥³âµµ 2025 ¹ßÇ¥Áö Alzheimer¡¯s & Dementia

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

»ï¼º¼­¿ïº´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
1599-3114

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

»ï¼º¼­¿ïº´¿øÀº 1994³â °³¿øÇÑ Á¾ÇÕ ÀÇ·á±â°üÀ¸·Î º»°ü, º°°ü, ¾Ïº´µ¿À¸·Î ±¸¼ºµÅ ÀÖÀ¸¸ç ¾à 1979º´»ó ±Ô¸ð¸¦ °®Ãß°í ÀÖ´Ù. 2014³â ¾ç¼ºÀÚ Ä¡·á¼¾ÅÍ, 2015³â ¹Ì·¡ ÀÇÇаüÀÌ ¿Ï°øµÆÀ¸¸ç, ÇöÀç 2019³â ¿Ï°øÀ» ¸ñÇ¥·Î Åë¿øÄ¡·á¼¾ÅÍ °ø»ç¸¦ ÁøÇàÇϰí ÀÖ´Ù. ȯÀÚ ÇູÀ» À§ÇÑ ÀÇ·á Çõ½Å ±¸Çö, º´¿ø-¿¬±¸¼Ò-Çб³-±â¾÷ü¸¦ ¿¬°áÇÏ´Â ¹ÙÀÌ¿À ÇコÄÉ¾î ¿¬±¸ ¹× ¿¬°è »ê¾÷ÀÇ ±Û·Î¹ú Çãºê¸¦ ¸ñÇ¥·Î ÇÑ´Ù.

»ï¼º¼­¿ïº´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã °­³²±¸ ÀÏ¿ø·Î 81

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä